Pharmaceuticals

Thrive in a Digitally Transforming Pharmaceutical Industry

The pharmaceutical sector and broader life sciences industry are undergoing rapid digital transformation, evidenced by partnerships and competition between pharmaceutical giants and tech leaders like the GAFAM.

Companies are pursuing mergers and acquisitions to expand product portfolios or enter new markets. These transactions, often complex and multi-dimensional, create significant challenges in financial reporting and regulatory compliance. Businesses navigating these transitions require expert advice to address these challenges effectively.

BDO’s Expertise for the Pharmaceutical Sector

BDO provides tailored support from securing research funding to conducting due diligence for acquisitions or divestitures in pharmaceuticals, biotech, and medical device manufacturing.

How We Help

  • Guide clients in accessing capital to fuel innovation and development.
  • Identify tax opportunities to create value.
  • Structure operations for maximum efficiency.
  • Provide multidisciplinary services: accounting, audit, tax, HR, valuations, and consulting.

Partner with us to address your challenges and seize growth opportunities in the pharmaceutical industr

Analyze the existing situation to improve your organization

There are many challenges faced by companies in the pharmaceutical industry. Here are some examples:

  • Innovation: It is essential to continue innovating to remain competitive in the pharmaceutical industry. This involves developing new molecules and technologies, as well as finding ways to produce drugs more efficiently and at lower costs;
  • Competition: The pharmaceutical industry is highly competitive, which can make it difficult to secure funding and commercialize new drugs;
  • Regulation: The pharmaceutical industry is heavily regulated, which can be costly and complex for companies;
  • Accessibility: Medications can be expensive, making it difficult for some patients to access them. Pharmaceutical companies must find ways to make their drugs more accessible while maintaining their financial viability;
  • Research and Development Risks: Developing new drugs involves risks, particularly regarding costs and development times. It can be challenging to accurately predict these costs and timelines, posing a challenge for pharmaceutical companies.

Your Key Contacts

Jacques Marquay
Director,  Advisory Department